Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'PharmaVitae Merger Analysis Tool' returned 9 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile   Datamonitor, June 2010, Pages: 64 analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08 Operating costs and profit analysis Eisai Co. Ltd: PharmaVitae Profile   Datamonitor, June 2010, Pages: 68 /expiry configuration, 2008-14 Molecule type analysis Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales Merck & Co. Inc: PharmaVitae Profile   Datamonitor, June 2010, Pages: 107 -15 Molecule type analysis Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003 F. Hoffmann-La Roche Ltd.: PharmaVitae Profile   Datamonitor, July 2010, Pages: 117 analysis, 2009-15 Launch/core/expiry configuration, 2009-15 Molecule type analysis Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted Bayer Schering Pharma AG: PharmaVitae Profile   Datamonitor, June 2010, Pages: 116 enhanced the company's HealthCare division -Assess how an increased healthcare focus and merger-related synergies will drive an increase in operating profit Chapter 1 About this profile PharmaVitae Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile   Datamonitor, Oct 2009, Pages: 113 /expiry configuration, 2008-14 Molecule type analysis Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Profile   Datamonitor, April 2009, Pages: 98 -13 Externalization analysis Externalization analysis, 2001-07 Externalization analysis, 2007-13 CHAPTER 6 COMPANY FINANCIALS Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales Sepracor Inc.: PharmaVitae Profile   Datamonitor, March 2009, Pages: 105 , 2001-07 Externalization analysis, 2007-13 CHAPTER 6 COMPANY FINANCIALS Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2001 Schering-Plough Corporation: PharmaVitae Profile   Datamonitor, March 2009, Pages: 163 analysis, 2007-13 Externalization analysis Externalization analysis, 2001-07 Externalization analysis, 2007-13 CHAPTER 6 COMPANY FINANCIALS Key findings Reconciliation between PharmaVitae-formatted Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network